Quick Comparison
| EGF (Epidermal Growth Factor) | Niacinamide | |
|---|---|---|
| Typical Concentration | Concentrations vary by product (typically measured in ppm or sh-oligopeptide-1 percentage). Applied once or twice daily. Best used after procedures or on aging skin. Apply before oils/occlusives. Store in refrigerator for stability. | Concentrations: 2-10%. 5% is the most studied concentration and provides the best balance of efficacy and tolerability. Higher concentrations (10%) are available but may cause irritation in sensitive skin without proportional benefit. Apply morning and/or night. |
| Application | Topical (serum, cream, ampoule). Apply to clean skin. Temperature-sensitive — some products require refrigeration. | Topical (serum, moisturizer, toner). Water-soluble. Stable in formulation. Compatible with most actives. |
| Research Papers | 10 papers | 10 papers |
| Categories |
Mechanism of Action
EGF (Epidermal Growth Factor)
EGF binds EGFR/ErbB1 on keratinocytes and fibroblasts, triggering dimerization and autophosphorylation. Activates MAPK/ERK (Ras-Raf-MEK-ERK) and PI3K/AKT pathways, promoting proliferation, migration (actin reorganization, focal adhesion turnover), and differentiation. Upregulates cyclin D1, inhibits p27. Stimulates fibroblast collagen types I/III and hyaluronic acid via HAS2. In wound healing, accelerates re-epithelialization via keratinocyte migration and reduces scarring via TGF-beta modulation. For anti-aging, promotes cellular renewal and extracellular matrix production. Theoretical cancer concern from EGFR's growth role — topical EGF has not been shown to penetrate to basal layer or systemic circulation significantly.
Niacinamide
Niacinamide is converted to NAD+ via the Preiss-Handler pathway—essential for cellular respiration, DNA repair (PARP), and sirtuin regulation. In keratinocytes, it upregulates serine palmitoyltransferase and fatty acid elongases, increasing ceramide synthesis and strengthening the barrier. It inhibits melanosome transfer by downregulating protease-activated receptor-2 (PAR-2) on keratinocytes—brightening without tyrosinase inhibition. In sebocytes, it normalizes lipid synthesis and reduces sebum (possibly via AMPK). Niacinamide inhibits NF-kB translocation, suppressing IL-1beta, TNF-alpha, and IL-8. It inhibits phosphodiesterase, increasing cAMP and modulating keratinocyte differentiation. These multi-pathway effects explain broad efficacy across barrier repair, brightening, acne, and anti-aging.
Risks & Safety
EGF (Epidermal Growth Factor)
Common
Very well-tolerated.
Serious
Theoretical concern about promoting growth of pre-existing skin cancers (unproven but debated).
Rare
Mild irritation.
Niacinamide
Common
Very well-tolerated at 2-5%. Flushing/redness at concentrations above 5% in some individuals.
Serious
None documented.
Rare
Contact dermatitis (uncommon). Old advice to avoid combining with vitamin C is largely debunked at product pH levels.
Full Profiles
EGF (Epidermal Growth Factor) →
A signaling protein that stimulates cell growth, proliferation, and differentiation. In skincare, EGF promotes wound healing, skin renewal, and collagen production. Originally used in medical wound care and post-laser recovery, it has become popular in Korean skincare for anti-aging. It is one of the few growth factors with evidence for topical skincare efficacy.
Niacinamide →
A true multitasker — niacinamide (vitamin B3) addresses almost every skin concern simultaneously. It strengthens the skin barrier by boosting ceramide production, reduces hyperpigmentation by inhibiting melanosome transfer, controls sebum production, minimizes pore appearance, reduces redness, and has anti-aging benefits. One of the most versatile and well-tolerated actives in skincare.